Skip to content

13F-HR filed by Rosalind Advisors, Inc.

Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2025-09-30, filed 2025-11-13, with 39 holding rows worth $292,563,470.

Accession
0001622627-25-000038
Filed
2025-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2025

A holdings report, 39 entries on the cover page, a total value of $292,563,470 stated on the cover page (in dollars after the unit check, H1), rows summing to $292,563,470 with VALUE read as dollars as filed, 13F file number 028-23857. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
DELCATH SYSTEMS INC24661P807COMMON STOCK3,300,389$33,003,890dollars as filed
CYTOKINETICS INC23282W605COM NEW400,000$21,984,000dollars as filed
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK2,076,840$19,439,222dollars as filed
VERASTEM INC92337C203COMMON STOCK1,929,563$17,038,041dollars as filed
REZOLUTE INC76200L309COMMON STOCK1,807,202$16,987,698dollars as filed
XERIS BIOPHARMA HOLDINGS INC98422E103COM1,795,766$14,617,535dollars as filed
SAVARA INC805111101COM4,000,000$14,280,000dollars as filed
MEDIWOUND LTDM68830112COMMON STOCK749,054$13,497,953dollars as filed
VIRIDIAN THERAPEUTICS INC92790C104COM600,000$12,948,000dollars as filed
CG ONCOLOGY INC156944100COMMON STOCK300,000$12,084,000dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS100,000$10,671,000dollars as filed
IDEAYA BIOSCIENCES INC COM45166A102Stock350,000$9,523,500dollars as filed
INSPIREMD INC45779A846COM3,905,743$9,412,840dollars as filed
EYEPOINT INC COM NEW30233G209Stock650,000$9,256,000dollars as filed
MIND MEDICINE MINDMED INC60255C885COM NEW750,000$8,842,500dollars as filed
CYBIN INC23256X407COM NEW1,500,000$8,835,000dollars as filed
FRACTYL HEALTH INC35168W103COM5,000,000$7,950,000dollars as filed
ATYR PHARMA INC002120202COM NEW1,039,080$7,564,502dollars as filed
UNIQURE NVN90064101SHS125,000$7,296,250dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK1,544,607$5,282,555dollars as filed
OCULAR THERAPEUTIX INC67576A100COM400,000$4,676,000dollars as filed
ATYR PHARMA INC002120952COM NEW1,570,200$4,469,525dollars as filedput
TALPHERA INC00444T209COM NEW4,385,757$3,917,358dollars as filed
PROFOUND MED CORP74319B502COM NEW692,185$3,384,784dollars as filed
MYOMO INC62857J201COM NEW3,790,788$3,381,382dollars as filed
POLYPID LTDM8001Q126COM918,668$3,063,757dollars as filed
INVESCO QQQ TR46090E953PUT250,000$1,557,000dollars as filedput
BIOFRONTERA INC09077D209COM NEW1,140,764$1,123,652dollars as filed
ASTRIA THERAPEUTICS INC COM04635X102Stock1,542,520$1,112,773dollars as filed
SPDR SERIES TRUST78464A950PUT2,128,300$950,638dollars as filedput
TREVI THERAPEUTICS INC COM89532M101Stock100,000$915,000dollars as filed
VERASTEM INC92337C903COM NEW646,500$898,215dollars as filedcall
KURA ONCOLOGY INC COM50127T109Stock100,000$885,000dollars as filed
SPDR S&P 500 ETF TR78462F953PUT300,000$717,500dollars as filedput
REZOLUTE INC76200L909CALL263,100$546,360dollars as filedcall
IDEAYA BIOSCIENCES INC45166A902COM35,900$236,940dollars as filedcall
REPLIMUNE GROUP INC76029N906CALL511,400$183,100dollars as filedcall
ISHARES TR464287955PUT200,000$20,000dollars as filedput
SCHOLAR ROCK HLDG CORP80706P953COM100,000$10,000dollars as filedput

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001622627-25-000038this filing2025-11-13acceptance time not in the bulk data set